Macrolactam immunomodulators (tacrolimus and pimecrolimus): New horizons in the topical treatment of inflammatory skin diseases

Marcelo H. Grunwald; Dan Ben Amitai; Boaz Amichai

doi:10.1111/j.1346-8138.2004.tb00564.x

Macrolactam immunomodulators (tacrolimus and pimecrolimus): New horizons in the topical treatment of inflammatory skin diseases

Marcelo H. Grunwald, Dan Ben Amitai, Boaz Amichai

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

Tacrolimus and pimecrolimus are new macrolactam immunomodulators which were developed for the treatment of inflammatory skin diseases, mainly atopic dermatitis. In this article, we review the pharmacologic properties of the drugs, their side effects, and their clinical uses.

Original language	English
Pages (from-to)	592-602
Number of pages	11
Journal	Journal of Dermatology
Volume	31
Issue number	8
DOIs	https://doi.org/10.1111/j.1346-8138.2004.tb00564.x
State	Published - 1 Jan 2004

Keywords

Macrolactam immunomodulators
Pimecrolimus
Tacrolimus

ASJC Scopus subject areas

Dermatology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1346-8138.2004.tb00564.x

Cite this

@article{9292bea74d104c3cae273194949510c1,

title = "Macrolactam immunomodulators (tacrolimus and pimecrolimus): New horizons in the topical treatment of inflammatory skin diseases",

abstract = "Tacrolimus and pimecrolimus are new macrolactam immunomodulators which were developed for the treatment of inflammatory skin diseases, mainly atopic dermatitis. In this article, we review the pharmacologic properties of the drugs, their side effects, and their clinical uses.",

keywords = "Macrolactam immunomodulators, Pimecrolimus, Tacrolimus",

author = "Grunwald, {Marcelo H.} and Amitai, {Dan Ben} and Boaz Amichai",

year = "2004",

month = jan,

day = "1",

doi = "10.1111/j.1346-8138.2004.tb00564.x",

language = "English",

volume = "31",

pages = "592--602",

journal = "Journal of Dermatology",

issn = "0385-2407",

publisher = "John Wiley and Sons Inc.",

number = "8",

}

TY - JOUR

T1 - Macrolactam immunomodulators (tacrolimus and pimecrolimus)

T2 - New horizons in the topical treatment of inflammatory skin diseases

AU - Grunwald, Marcelo H.

AU - Amitai, Dan Ben

AU - Amichai, Boaz

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Tacrolimus and pimecrolimus are new macrolactam immunomodulators which were developed for the treatment of inflammatory skin diseases, mainly atopic dermatitis. In this article, we review the pharmacologic properties of the drugs, their side effects, and their clinical uses.

AB - Tacrolimus and pimecrolimus are new macrolactam immunomodulators which were developed for the treatment of inflammatory skin diseases, mainly atopic dermatitis. In this article, we review the pharmacologic properties of the drugs, their side effects, and their clinical uses.

KW - Macrolactam immunomodulators

KW - Pimecrolimus

KW - Tacrolimus

UR - http://www.scopus.com/inward/record.url?scp=4544363982&partnerID=8YFLogxK

U2 - 10.1111/j.1346-8138.2004.tb00564.x

DO - 10.1111/j.1346-8138.2004.tb00564.x

M3 - Review article

C2 - 15492431

AN - SCOPUS:4544363982

SN - 0385-2407

VL - 31

SP - 592

EP - 602

JO - Journal of Dermatology

JF - Journal of Dermatology

IS - 8

ER -

Macrolactam immunomodulators (tacrolimus and pimecrolimus): New horizons in the topical treatment of inflammatory skin diseases

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this